Japan In-vitro Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)

The market is segmented By Technique, Product (Instrument, Reagent, Other Product), Usability, Application and End Users

Market Snapshot

Picture1Japan In-vitro Diagnostics
Study Period:

2016-2024

Base Year:

2018

CAGR:

4.5 %

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The field of in-vitro diagnostics has witnessed several changes and additions to its gamut of offerings in the recent past. There has been a paradigm shift from traditional diagnostics to a new generation diagnostics that work on the gene level. This was possible due to the inclusion of advanced technology, such as genetic testing, molecular diagnostics, Polymerase Chain Reaction (PCR), and Next-Generation Sequencing (NGS). Fast turnaround, reliability, user-friendliness, and predictability of predisposed diseases are few significant qualities, which helped these technologies attain their share in major offerings of diagnosis providers around the world and especially Japan. Increasing demand from the educated public for more information about their predisposition for serious diseases, and how these potential illnesses can be detected at an early stage, is driving the market for Japan in-vitro diagnostics. Furthermore, a growing burden of chronic and infectious diseases, increasing use of point of care (POC) diagnostics, and surging number of private hospitals and independent testing laboratories are some of the other factors contributing to the growth of the market. However, lack of proper reimbursement system in Japan, stringent regulations and limited budget of hospitals and laboratories in developing economies are also restraining the japan in-vitro diagnostics market.

Scope of the Report

As per the scope of this report, in vitro diagnostics involves medical devices and consumables that are utilized to perform in vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as chronic diseases.

By Test Type
Clinical Chemistry
Molecular Diagnostics
Immuno Diagnostics
Haematology
Other Types
By Product
Instrument
Reagent
Others
By Usability
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Disease
Nephrology
Other Applications
By End Users
Diagnostic Laboratories
Hospitals & Clinics
Other End Users

Report scope can be customized per your requirements. Click here.

Key Market Trends

Instruments segment dominates the Japan In-vitro Diagnostics Market

The population of Japan is aging rapidly. The health life expectancy has shown a dramatic increase in recent years. This trend is expected to shift the focus of the medical device industry from treatment to prevention. The IVD instruments are expected to play a major role in this shift. IVD instruments, such as glucose meters, chemical analyzers, clinical chemistry analyzers, hematology analyzers, urine analyzers, and immunochemistry analyzers are expected to find increased applications, with people starting to prefer prevention over treatment. Companies are increasing their R&D expenditures, and are continuously bringing integrated and closed systems to the market, in order to retain their market share. Moreover, outsourcing in instrumentation is increasing gradually instead of in-house instrumentation, owing to increased efficiency, speed, and low operating costs realized, due to the economics of scale. The aforementioned factors are expected to increase the market, during the forecast period.

Picture1

To understand key trends, Download Sample Report

Competitive Landscape

The market comprises of major market players and these players are moreover focusing on research and development in order to form a stable and safe formulation. The market has been noticing technological developments on a large scale for the past couple of years. For instance, in July 2017 Sysmex Corporation and bioMérieux announced that they had agreed to transfer all of Sysmex holdings in Sysmex bioMérieux Co., Ltd. (Tokyo, Japan) to bioMérieux. Key players in Japan In-vitro Diagnostics market are Biomérieux, Abbott Laboratories, Bayer AG, Bio-Rad Laboratories, Inc., Danaher Corporation, Johnson & Johnson, Nippon Becton Dickinson Company, Roche Diagnostics and Siemens amongst others.

Major Players

  1. Abbott
  2. Becton Dickinson & Company
  3. Biomerieux
  4. Bio-rad Laboratories Inc.
  5. Qiagen

* Complete list of players covered available in the table of contents below

Japan In-vitro Diagnostics

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High Prevalence of Chronic Diseases

      2. 4.2.2 Increasing Use of Point-of-Care (POC) Diagnostics Spurring the IVD Market

      3. 4.2.3 Advanced Technologies Fueling the Japan IVD Market

      4. 4.2.4 Increasing Awareness and Acceptance of Personalized

        1. 4.2.4.1 Medicine and Companion Diagnostics

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Proper Reimbursement

      2. 4.3.2 Stringent Regulatory Framework

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 Clinical Chemistry

      2. 5.1.2 Molecular Diagnostics

      3. 5.1.3 Immuno Diagnostics

      4. 5.1.4 Haematology

      5. 5.1.5 Other Types

    2. 5.2 By Product

      1. 5.2.1 Instrument

      2. 5.2.2 Reagent

      3. 5.2.3 Others

    3. 5.3 By Usability

      1. 5.3.1 Disposable IVD Devices

      2. 5.3.2 Reusable IVD Devices

    4. 5.4 By Application

      1. 5.4.1 Infectious Disease

      2. 5.4.2 Diabetes

      3. 5.4.3 Cancer/Oncology

      4. 5.4.4 Cardiology

      5. 5.4.5 Autoimmune Disease

      6. 5.4.6 Nephrology

      7. 5.4.7 Other Applications

    5. 5.5 By End Users

      1. 5.5.1 Diagnostic Laboratories

      2. 5.5.2 Hospitals & Clinics

      3. 5.5.3 Other End Users

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 F Hoffmann La Roche

      3. 6.1.3 Becton Dickinson & Company

      4. 6.1.4 Danaher Corporation

      5. 6.1.5 Biomerieux

      6. 6.1.6 Bio-rad Laboratories Inc.

      7. 6.1.7 Thermofisher Scientific Inc.

      8. 6.1.8 Qiagen

      9. 6.1.9 Siemens Healthineers

      10. 6.1.10 Sysmex

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information